U.S. Trade Distributors Stock News

In the past week, Robert Half Inc. reported second-quarter 2026 results showing net income of US$26.32 million and diluted EPS of US$0.26, and issued third-quarter guidance calling for revenues of US$1.31 billion to US$1.41 billion and income per share of US$0.43 to US$0.53. Alongside these mixed results, the company pointed to stronger hiring intentions in its U.S. and Canadian surveys, underscoring ongoing demand for specialized talent solutions despite earlier earnings pressure. With...

Hotter, drier UK weather is putting fresh pressure on potato crops and crisp production costs, even as demand for snacks remains steady. That mix of rising input risks and resilient consumer appetite can matter a lot for packaged food stocks in 2026. Some companies may be better placed than others to handle higher irrigation expenses, crop variability and pricing decisions. This article looks at 3 stocks from our Consumer Staples, Packaged Foods & Snacks screener that appear positively...

China has introduced new obstacles for Western Digital and other chip manufacturers that affect operations and access to the Chinese market. These measures come alongside a major Chinese IPO and the start of state-backed mass production of chip-making machines. The developments create fresh uncertainty for NasdaqGS:WDC around supply chains and long term market positioning in China. Western Digital enters this phase of China related pressure after a very large 1 year return and a year to...

FormFactor (FORM) is back in focus after reporting second quarter results and updating its near term outlook, giving investors fresh data on sales, profitability, and expectations for the coming quarter. See our latest analysis for FormFactor. Despite FormFactor’s solid earnings update and new partnership announcements, the share price has fallen 26.4% over the past week and 42.1% over the past month. However, year to date the share price return is up 41% and the 1 year total shareholder...

In late July 2026, Western Midstream Partners, LP filed a shelf registration to issue up to US$929.33 million of common units, covering 19,389,239 securities. This filing gives the partnership flexibility to raise equity capital when needed, which could have implications for existing unitholder ownership and future financing choices. Next, we’ll explore how this potential equity issuance could reshape Western Midstream Partners’ investment narrative and its capital-intensive growth...

Charles Schwab stock has delivered a 66.8% return over the past three years, and the current checks suggest the shares may still be pricing in less than the company’s full intrinsic value based on the Excess Returns model. At the same time, traditional earnings multiples point to a level that looks about right rather than deeply discounted. A 66.8% gain over three years puts Charles Schwab in focus for investors asking whether recent strength has already captured most of the...

Investors who take an interest in CVB Financial Corp. ( NASDAQ:CVBF ) should definitely note that the Independent...

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...

We wouldn't blame Tenet Healthcare Corporation ( NYSE:THC ) shareholders if they were a little worried about the fact...

Some BancFirst Corporation ( NASDAQ:BANF ) shareholders may be a little concerned to see that the Non-Executive...

The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even...

Geopolitical shocks in the Middle East have pushed oil prices higher and widened refining crack spreads, putting Phillips 66 (PSX) in focus as investors reassess U.S. refiners' earnings power and capital return plans. See our latest analysis for Phillips 66. After a strong run, Phillips 66’s share price sits at US$206.81, with a 30 day share price return of 18.82% and a year to date share price return of 58.39%. The 1 year total shareholder return of 71.94% and 5 year total shareholder return...

Why New Oriental Education & Technology Group Stock Is Back on Investors’ Radar New Oriental Education & Technology Group (EDU) stock is in focus after the company reported stronger fourth quarter and full year 2026 results, along with fresh revenue guidance for fiscal 2027 and new shareholder return plans. See our latest analysis for New Oriental Education & Technology Group. The latest earnings, fresh revenue guidance and new shareholder returns have put New Oriental Education & Technology...

CBIZ stock has surged in recent weeks and now trades very close to the US$55 per share price implied in Grant Thornton Advisors' agreed all cash acquisition, while the company's broader valuation checks still suggest the shares lean cheap rather than stretched. Over the past 5 years CBIZ has delivered a total return of about 70%, which points to meaningful long term value creation for shareholders compared to shorter term swings. The proposed US$5b all cash takeover by Grant Thornton...

Ecolab Inc. reported its second-quarter 2026 results, with revenue rising to US$4,415.4 million and net income reaching US$534.9 million, and also completed a share repurchase of 1,200,000 shares for US$316.13 million under its long-running buyback program. The company lifted its full-year 2026 adjusted earnings outlook after double-digit earnings growth, supported by stronger pricing, productivity gains, and rapid expansion in its Life Sciences and Global High-Tech businesses. We will now...

Outlook Therapeutics stock has had a very weak run over the past five years, yet recent FDA approval for its lead drug has put fresh attention on whether the current US$1.00 share price is justified given the broader valuation checks. The share price has declined 97.9% over the past five years, which means long term holders have absorbed very heavy losses that set a low base for any future rerating. The recent FDA approval of LYTENAVA for wet age related macular degeneration can support...

Sunrun stock is trading around US$9.47 after a very steep 82.3% decline over the past 5 years, and the valuation checks send a mixed message about whether that reset has gone far enough. Over 5 years, Sunrun shareholders have seen the share price fall 82.3%. This puts the current valuation in the context of a long and painful reset rather than a short term swing. Future demand for residential solar and Sunrun's ability to turn that demand into steady cash flows can support the current price...

Earlier this week, Jefferies analysts said Flutter Entertainment may be at an inflection point as worries about prediction market competition ease, citing recovering online sports betting trends and minimal evidence of share loss. Jefferies also highlighted potential new profit streams from market-making, FanDuel Predicts and regulatory leverage tied to prediction markets, which could reshape how investors view Flutter’s earnings mix. Next, we’ll explore how Jefferies’ focus on new profit...

Markets are searching for companies that can keep growing even as inflation, energy costs and central bank decisions pull in different directions. The Fast Growing Stocks With High Insider Ownership screener focuses on businesses where analysts and management see room for further expansion, and where insiders have meaningful skin in the game. That combination can appeal if you want growth that is supported by both external research and internal conviction. In this article you will see 3...

Motorola Solutions (MSI) is back in focus as investors look ahead to its upcoming second quarter 2026 earnings release, with growing attention on expected earnings and revenue figures as well as the company’s record of beating past estimates. See our latest analysis for Motorola Solutions. At a latest share price of US$434.20, Motorola Solutions has recently gained momentum, with a 7 day share price return of 7.39% and a year to date share price return of 13.96%. The 5 year total shareholder...

Amneal Pharmaceuticals (AMRX) has drawn fresh attention after receiving U.S. Food and Drug Administration approval for additional strengths and vial sizes of its iohexol injection, which expands its radiographic contrast agent offering. See our latest analysis for Amneal Pharmaceuticals. The FDA approval arrives at a time when Amneal Pharmaceuticals’ share price momentum is strong, with a 30 day share price return of 10.47% and a year to date share price return of 50.87%, alongside a 1 year...

Why PulteGroup Stock Is Back In Focus After Q2 Results PulteGroup (PHM) moved into the spotlight after reporting second quarter 2026 earnings that showed lower revenue and net income compared with the same period a year earlier, alongside an update on its long running share repurchase program. See our latest analysis for PulteGroup. At a share price of $132.31, PulteGroup has seen its 7 day share price return rise 4.39% while the 30 day return is down 4.08%. The 1 year total shareholder...

Old Second Bancorp (OSBC) shares are in focus after second quarter results paired higher net interest income and net income with a sharp rise in net charge offs and a maintained quarterly dividend. See our latest analysis for Old Second Bancorp. The second quarter update and higher net charge offs come after a period of strong momentum for Old Second Bancorp, with the share price up 22.71% over 90 days and a 1 year total shareholder return of 47.94%. This suggests recent earnings and buyback...

Trinity Capital (TRIN) was removed from the NASDAQ Composite Index on 24 July 2026. This event can prompt index tracking funds and benchmarked portfolios to adjust holdings and reassess exposure to the stock. See our latest analysis for Trinity Capital. Trinity Capital's removal from the NASDAQ Composite comes after a period where the share price rose 16.74% year to date and the 1 year total shareholder return reached 35.24%. This points to momentum that has built over a longer horizon, even...